Abstract
Among the lipoxygenases, a diverse family of fatty acid dioxygenases with varying tissue-specific expression, 15-lipoxygenase (15-LOX) was found to be involved in many aspects of human cancer, such as angiogenesis, chronic inflammation, metastasis formation, and direct and indirect tumor suppression. Herein, evidence for the expression and action of 15-LOX and its orthologs in various neoplasms, including solid tumors and hematologic malignancies, is reviewed. The debate surrounding the impact of 15-LOX as either a tumor-promoting or a tumor-suppressing enzyme is highlighted and discussed in the context of its role in other biological systems.
Original language | American English |
---|---|
Pages (from-to) | 16-22 |
Number of pages | 7 |
Journal | Prostaglandins and Other Lipid Mediators |
Volume | 106 |
DOIs | |
State | Published - Oct 2013 |
Keywords
- Arachidonic acid
- Docosahexaenoic acid
- Lipoxygenase
- Neoplastic growth
- Tumor biology
All Science Journal Classification (ASJC) codes
- Biochemistry
- Physiology
- Cell Biology
- Pharmacology